SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
Open accessAbstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection often caused severe end stage lung disease and organizing phase diffuse alveolar damage, especially in the elderly. The virus-host interactions that governed development of these acute end stage lung diseases and death are unknown. To address this question, we evaluated the role of innate immune signaling in protection from human (Urbani) and a recombinant mouse adapted SARS-CoV, designated rMA15. In contrast to most models of viral pathogenesis, infection of type I, type II or type III interferon knockout mice (129 background) with either Urbani or MA15 viruses resulted in clinical disease outcomes, including transient weight loss, denuding bronchiolitis and alveolar inflammation and recovery, identical to that seen in infection of wildtype mice. This suggests that type I, II and III interferon signaling play minor roles in regulating SARS pathogenesis in mouse models. In contrast, infection of STAT1-/- mice resulted in severe disease, high virus titer, extensive pulmonary lesions and 100% mortality by day 9 and 30 post-infection with rMA15 or Urbani viruses, respectively. Non-lethal in BALB/c mice, Urbani SARS-CoV infection in STAT1-/- mice caused disseminated infection involving the liver, spleen and other tissues after day 9. These findings demonstrated that SARS-CoV pathogenesis is regulated by a STAT1 dependent but type I, II and III interferon receptor independent, mechanism. In contrast to a well documented role in innate immunity, we propose that STAT1 also protects mice via its role as an antagonist of unrestrained cell proliferation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Characterization of a recombinant mouse-adapted SARS-CoV strain rMA15 in STAT1 knockout mice revealed increased pathology in the absence of STAT1 signaling, including evidence of pulmonary fibrotic lesions.
“Characterization of a recombinant mouse-adapted SARS-CoV strain (rMA15) in STAT1 knockout mice revealed increased pathology in the absence of STAT1 signaling, including evidence of pulmonary fibrotic lesions (52).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574 · see citing works
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G. E., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F. G., Dickensheets, H. L., & Donnelly, R. P. (2002) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,867 · see citing works
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808 · see citing works
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,522 · see citing works
Viruses and interferon: a fight for supremacy
Katze, M. G., He, Y., & Gale, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri888 · Cited by 1,419 · see citing works
The role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201 · see citing works
Donnelly, C. A., Ghani, A. C., Leung, G. M., Hedley, A. J., Fraser, C., Riley, S., Abu-Raddad, L. J., Ho, L.-M., Thach, T.-Q., Chau, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13410-1 · Cited by 940 · see citing works
Kopecky-Bromberg, S. A., Martínez‐Sobrido, L., Frieman, M. B., Baric, R. S., & Palese, P. (2006) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 662 · see citing works
Self-citationChan‐Yeung, M., & Xu, R. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00518.x · Cited by 639 · see citing works
Interferon signalling network in innate defence
Takaoka, A., & Yanai, H. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00716.x · Cited by 586 · see citing works
Yuan, W., & Krug, R. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.362 · Cited by 532 · see citing works
Frieman, M. B., Yount, B. L., Heise, M. T., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 508 · see citing works
Self-citationInvolvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus
Haynes, L. M., Moore, D. D., Kurt‐Jones, E. A., Finberg, R. W., Anderson, L. J., & Tripp, R. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10730-10737.2001 · Cited by 496 · see citing works
Antiviral innate immunity pathways
Seth, R. B., Sun, L., & Chen, Z. J. (2006) · Cell Research · doi:10.1038/sj.cr.7310019 · Cited by 492 · see citing works
The Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V. E., Paragas, J., Klenk, H., García‐Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 477 · see citing works
Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02349-05 · Cited by 463 · see citing works
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B. L., Vogel, L., Herman, B. D., Sheahan, T., Heise, M. T., Genrich, G. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030005 · Cited by 447 · see citing works
Self-citationThe virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
Levy, D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00027-7 · Cited by 428 · see citing works
Subbarao, K., McAuliffe, J. M., Vogel, L., Fahle, G. A., Fischer, S. H., Tatti, K. M., Packard, M. M., Shieh, W., Zaki, S. R., & Murphy, B. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 397 · see citing works
Self-citationCameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00527-07 · Cited by 386 · see citing works
Frieman, M. B., Ratia, K. M., Johnston, R. E., Mesecar, A. D., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.02220-08 · Cited by 370 · see citing works
Self-citationWathelet, M. G., Orr, M., Frieman, M. B., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.00702-07 · Cited by 339 · see citing works
Self-citationGlass, W. G., Subbarao, K., Murphy, B. R., & Murphy, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4030 · Cited by 337 · see citing works
Self-citationPulmonary pathology of severe acute respiratory syndrome in Toronto
Hwang, D. M., Chamberlain, D. W., Poutanen, S. M., Low, D. E., Asa, S. L., & Butany, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800247 · Cited by 332 · see citing works
Rodriguez, J. J., Parisien, J.-P., & Horvath, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11476-11483.2002 · Cited by 307 · see citing works
Type I IFN Modulates Innate and Specific Antiviral Immunity
Durbin, J. E., Fernández-Sesma, A., Lee, C., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanović, S., García‐Sastre, A., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4220 · Cited by 286 · see citing works
The role of the Type I interferon response in the resistance of mice to filovirus infection
Bray, M. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-6-1365 · Cited by 228 · see citing works
Tyrphostins and Other Tyrosine Kinase Inhibitors
Levitzki, A., & Mishani, E. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142657 · Cited by 225 · see citing works
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Sheahan, T. P., Morrison, T. E., Funkhouser, W., Uematsu, S., Akira, S., Baric, R. S., & Heise, M. T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000240 · Cited by 207 · see citing works
Self-citationProtective Role of Beta Interferon in Host Defense against Influenza A Virus
Koerner, I., Kochs, G., Kalinke, U., Weiß, S., & Staeheli, P. (2006) · Journal of Virology · doi:10.1128/jvi.01718-06 · Cited by 201 · see citing works
Keller, B. C., Fredericksen, B. L., Samuel, M. A., Mock, R. E., Mason, P. W., Diamond, M., & Gale, M. (2006) · Journal of Virology · doi:10.1128/jvi.00768-06 · Cited by 198 · see citing works
Roberts, A., Paddock, C. D., Vogel, L., Butler, E. L., Zaki, S. R., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5833-5838.2005 · Cited by 196 · see citing works
Self-citationRockx, B., Baas, T., Zornetzer, G. A., Haagmans, B. L., Sheahan, T. P., Frieman, M. B., Dyer, M. D., Teal, T. H., Proll, S. C., van den Brand, J. M. A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00127-09 · Cited by 175 · see citing works
Self-citationThe Role of IFN in Respiratory Syncytial Virus Pathogenesis
Durbin, J. E., Johnson, T. R., Durbin, R. K., Mertz, S. E., Morotti, R. A., Peebles, R. S., & Graham, B. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2944 · Cited by 172 · see citing works
Klampfer, L. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776056491 · Cited by 171 · see citing works
Pathogenesis of severe acute respiratory syndrome
Lau, Y., & Peiris, M. J. S. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.05.009 · Cited by 168 · see citing works
Nicholls, J. M., BUTANY, J. W., Poon, L. L. M., Chan, K. H., Beh, S.-L., Poutanen, S. M., Peiris, M. J. S., & Wong, M. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030027 · Cited by 151 · see citing works
Hogan, R. J., Gao, G., Rowe, T., Bell, P. L., Flieder, D. B., Paragas, J., Kobinger, G., Wivel, N. A., Crystal, R. G., Boyer, J. L., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11416-11421.2004 · Cited by 132 · see citing works
Salvatore, M., Basler, C. F., Parisien, J.-P., Horvath, C. M., Bourmakina, S. V., Zheng, H., Muster, T., Palese, P., & García‐Sastre, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1206-1212.2002 · Cited by 119 · see citing works
STAT Signaling in the Pathogenesis and Treatment of Cancer
Frank, D. A. (1999) · Molecular Medicine · doi:10.1007/bf03403538 · Cited by 116 · see citing works
Multiple Host Barriers Restrict Poliovirus Trafficking in Mice
Kuss-Duerkop, S. K., Etheredge, C. A., & Pfeiffer, J. K. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000082 · Cited by 103 · see citing works
Paul, N. S., Roberts, H. C., BUTANY, J. W., Chung, T., Gold, W. L., Mehta, S., Konen, E., Rao, A., Provost, Y. L., Hong, H., et al. (2004) · Radiographics · doi:10.1148/rg.242035193 · Cited by 98 · see citing works
Ryman, K. D., White, L., Johnston, R. E., & Klimstra, W. B. (2002) · Viral Immunology · doi:10.1089/088282402317340233 · Cited by 95 · see citing works
Radiology of Severe Acute Respiratory Syndrome (SARS)
Ketai, L. H., Paul, N. S., & Wong, K.-T. T. (2006) · Journal of Thoracic Imaging · doi:10.1097/01.rti.0000213581.14225.f1 · Cited by 84 · see citing works
Yoon, P., Keylock, K. T., Hartman, M. E., Freund, G. G., & Woods, J. A. (2003) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.11.010 · Cited by 76 · see citing works
Role for Innate IFNs in Determining Respiratory Syncytial Virus Immunopathology
Johnson, T. R., Mertz, S. E., Gitiban, N., Hammond, S., LeGallo, R., Durbin, R. K., & Durbin, J. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7234 · Cited by 72 · see citing works
Haller, O., Arnheiter, H., Gresser, I., & Lindenmann, J.-M. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.154.1.199 · Cited by 66 · see citing works
Effects of Type I Interferons on Friend Retrovirus Infection
Gerlach, N., Schimmer, S., Weiß, S., Kalinke, U., & Dittmer, U. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3438-3444.2006 · Cited by 59 · see citing works
How the SARS coronavirus causes disease: host or organism?
Lo, A. W. I., Tang, N. L. S., & To, K. (2005) · The Journal of Pathology · doi:10.1002/path.1897 · Cited by 55 · see citing works
Walters, D. M., Antao-Menezes, A., Ingram, J. L., Rice, A. B., Nyska, A., Tani, Y., Kleeberger, S. R., & Bonner, J. C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61210-2 · Cited by 55 · see citing works
Severe Acute Respiratory Syndrome Coronavirus Protein 6 Is Required for Optimal Replication
Zhao, J., Falcón, A. M., Zhou, H., Netland, J., Enjuanes, L., Breña, P. P., & Perlman, S. M. (2008) · Journal of Virology · doi:10.1128/jvi.02371-08 · Cited by 54 · see citing works
Baas, T., Roberts, A., Teal, T. H., Vogel, L., Chen, J., Tumpey, T. M., Katze, M. G., & Subbarao, K. (2008) · Journal of Virology · doi:10.1128/jvi.00489-08 · Cited by 52 · see citing works
Self-citationAntao-Menezes, A., Turpin, E. A., Bost, P. C., Ryman-Rasmussen, J. P., & Bonner, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4200 · Cited by 34 · see citing works
Rockx, B., Baas, T., Zornetzer, G. A., Haagmans, B. L., Sheahan, T. P., Frieman, M. B., Dyer, M. D., Teal, T. H., Proll, S. C., van den Brand, J. M. A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01322-09 · Cited by 14 · see citing works
Self-citationPathogenesis of severe acute respiratory syndrome
Zhang, Ding-mei, LU, L., Jia-hai, Zhong, & Nan-shan (2008) · 中华医学杂志:英文版 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [23]Rockx B Baas T Zornetzer GA Haagmans B Sheahan T 2009 Early Upregulation of ARDS Associated Cytokines Promote Lethal Disease in an Aged Mouse Model of SARS-CoV Infection. J Virol PMC2704758 19420084
Cited by
Sorted by citations
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · see citing works
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510 · see citing works
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524 · see citing works
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · see citing works
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400 · see citing works
Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909 · see citing works
Weiss, S. R., & Leibowitz, J. L. (2011) · Advances in virus research · doi:10.1016/b978-0-12-385885-6.00009-2 · Cited by 899 · see citing works
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
Pal, M. S., Berhanu, G., Desalegn, C., & Kandi, V. (2020) · Cureus · doi:10.7759/cureus.7423 · Cited by 831 · see citing works
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Dinnon, K. H., Leist, S. R., Schäfer, A., Edwards, C. E., Martinez, D. R., Montgomery, S. A., West, A., Yount, B. L., Hou, Y. J., Adams, L. E., et al. (2020) · Nature · doi:10.1038/s41586-020-2708-8 · Cited by 675 · see citing works
Self-citationA decade after SARS: strategies for controlling emerging coronaviruses
Graham, R. L., Donaldson, E., & Baric, R. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3143 · Cited by 676 · see citing works
Self-citationNieto-Torres, J. L., DeDiego, M. L., Verdiá-Báguena, C., Jiménez-Guardeño, J. M., Regla-Nava, J. Á., Fernández‐Delgado, R., Castaño-Rodríguez, C., Alcaraz, A., Torres, J., Aguilella, V. M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004077 · Cited by 560 · see citing works
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C., Meyerholz, D. K., Agnihothram, S., Baric, R. S., David, C. S., & Perlman, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.006 · Cited by 496 · see citing works
Self-citationType I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Lokugamage, K. G., Hage, A., de Vries, M., Valero-Jimenez, A. M., Schindewolf, C., Dittmann, M., Rajsbaum, R., & Menachery, V. D. (2020) · Journal of Virology · doi:10.1128/jvi.01410-20 · Cited by 485 · see citing works
Totura, A. L., Whitmore, A. C., Agnihothram, S., Schäfer, A., Katze, M. G., Heise, M. T., & Baric, R. S. (2015) · mBio · doi:10.1128/mbio.00638-15 · Cited by 479 · see citing works
Self-citationGeneration of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
Sun, J., Zhuang, Z., Zheng, J. H., Li, K., Wong, R. L.-Y., Liu, D., Huang, J., He, J., Zhu, A., Zhao, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.010 · Cited by 434 · see citing works
Self-citationSARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Totura, A. L., & Baric, R. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.04.004 · Cited by 416 · see citing works
Self-citationType III interferons disrupt the lung epithelial barrier upon viral recognition
Broggi, A., Ghosh, S., Sposito, B., Spreafico, R., Balzarini, F., Cascio, A. L., Clementi, N., Santis, M. D., Mancini, N., Granucci, F., et al. (2020) · Science · doi:10.1126/science.abc3545 · Cited by 398 · see citing works
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
Liu, W. J., Zhao, M. J., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 395 · see citing works
Immune-mediated approaches against COVID-19
Florindo, H. F., Kleiner, R., Vaskovich‐Koubi, D., Acúrcio, R. C., Carreira, B., Yeini, E., Tiram, G., Liubomirski, Y., & Satchi‐Fainaro, R. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0732-3 · Cited by 342 · see citing works
Molecular pathology of emerging coronavirus infections
Gralinski, L. E., & Baric, R. S. (2014) · The Journal of Pathology · doi:10.1002/path.4454 · Cited by 315 · see citing works
Self-citationMechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Gralinski, L. E., Bankhead, A., Jeng, S., Menachery, V. D., Proll, S. C., Belisle, S. E., Matzke, M. M., Webb‐Robertson, B., Luna, M. L., Shukla, A. K., et al. (2013) · mBio · doi:10.1128/mbio.00271-13 · Cited by 310 · see citing works
Self-citationInteraction of SARS and MERS Coronaviruses with the Antiviral Interferon Response
Kindler, E., Thiel, V., & Weber, F. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.006 · Cited by 292 · see citing works
Ichikawa, A., Kuba, K., Morita, M., Chida, S., Tezuka, H., Hara, H., Sasaki, T., Ohteki, T., Ranieri, V. M., dos Santos, C. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0508oc · Cited by 289 · see citing works
Boisson‐Dupuis, S., Kong, X., Okada, S., Cypowyj, S., Puel, A., Abel, L., & Casanova, J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.04.011 · Cited by 287 · see citing works
Boudewijns, R., Thibaut, H. J., Kaptein, S. J. F., Li, R., Vergote, V., Seldeslachts, L., Weyenbergh, J. V., Keyzer, C. D., Bervoets, L., Sharma, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19684-y · Cited by 275 · see citing works
Peng, X., Gralinski, L. E., Armour, C. D., Ferris, M. T., Thomas, M. J., Proll, S. C., Bradel-Tretheway, B., Korth, M. J., Castle, J. C., Biery, M. C., et al. (2010) · mBio · doi:10.1128/mbio.00206-10 · Cited by 256 · see citing works
Self-citationJiménez-Guardeño, J. M., Nieto-Torres, J. L., DeDiego, M. L., Regla-Nava, J. Á., Fernández‐Delgado, R., Castaño-Rodríguez, C., & Enjuanes, L. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004320 · Cited by 250 · see citing works
Guo, Q., Zhao, Y., Li, J., Liu, J., Yang, X., Guo, X., Kuang, M., Xia, H., Zhang, Z., Cao, L., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.12.016 · Cited by 242 · see citing works
Self-citationInhibition of SARS–CoV-2 by type I and type III interferons
Felgenhauer, U., Schoen, A., Gad, H. H., Hartmann, R., Schaubmar, A. R., Failing, K., Drosten, C., & Weber, F. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013788 · Cited by 249 · see citing works
Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
Khoury, M., Cuenca, J., Cruz, F. F., Figueroa, F. E., Rocco, P. R. M., & Weiss, D. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.00858-2020 · Cited by 243 · see citing works
Type I interferons in viral control and immune regulation
Teijaro, J. R. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.01.001 · Cited by 242 · see citing works
Graham, R. L., Becker, M. M., Eckerle, L. D., Deming, M. E., Denison, M. R., & Baric, R. S. (2012) · Nature Medicine · doi:10.1038/nm.2972 · Cited by 230 · see citing works
Self-citationViral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections
Nelemans, T., & Kikkert, M. (2019) · Viruses · doi:10.3390/v11100961 · Cited by 224 · see citing works
DeDiego, M. L., Nieto-Torres, J. L., Jiménez-Guardeño, J. M., Regla-Nava, J. Á., Álvarez, E. A., Oliveros, J. C., Zhao, J., Fett, C., Perlman, S. M., & Enjuanes, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002315 · Cited by 213 · see citing works
Golden, J. W., Cline, C. R., Zeng, X., Garrison, A. R., Carey, B. D., Mucker, E. M., White, L. E., Shamblin, J. D., Brocato, R. L., Liu, J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142032 · Cited by 195 · see citing works
Venkataraman, T., & Frieman, M. B. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.03.022 · Cited by 193 · see citing works
Self-citationWong, L.-Y. R., & Perlman, S. M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00656-2 · Cited by 196 · see citing works
Animal models for SARS and MERS coronaviruses
Gretebeck, L., & Subbarao, K. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.06.009 · Cited by 181 · see citing works
Self-citationYang, D., Chu, H., Hou, Y., Chai, Y., Shuai, H., Lee, A. C.-Y., Zhang, X., Wang, Y., Hu, B., Huang, X., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa356 · Cited by 179 · see citing works
Animal and translational models of SARS-CoV-2 infection and COVID-19
Johansen, M. D., Irving, A. T., Montagutelli, X., Tate, M. D., Rudloff, I., Nold, M. F., Hansbro, N. G., Kim, R., Donovan, C., Liu, G., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00340-z · Cited by 169 · see citing works
Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology
Cleary, S. J., Pitchford, S. C., Amison, R. T., Carrington, R., Cabrera, C. L. R., Magnen, M., Looney, M. R., Gray, E., & Page, C. P. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15143 · Cited by 169 · see citing works
Edwards, C. E., Yount, B. L., Graham, R. L., Leist, S. R., Hou, Y. J., Dinnon, K. H., Sims, A. M., Swanstrom, J., Gully, K. L., Scobey, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2001046117 · Cited by 159 · see citing works
Self-citationSims, A. M., Tilton, S. C., Menachery, V. D., Gralinski, L. E., Schäfer, A., Matzke, M. M., Webb‐Robertson, B., Chang, J., Luna, M. L., Long, C., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02520-12 · Cited by 156 · see citing works
Self-citationJiménez-Guardeño, J. M., Regla-Nava, J. Á., Nieto-Torres, J. L., DeDiego, M. L., Castaño-Rodríguez, C., Fernández‐Delgado, R., Perlman, S. M., & Enjuanes, L. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005215 · Cited by 156 · see citing works
Intranasal Treatment with Poly(I·C) Protects Aged Mice from Lethal Respiratory Virus Infections
Zhao, J., Wohlford-Lenane, C., Zhao, J., Fleming, E., Lane, T. E., McCray, P. B., & Perlman, S. M. (2012) · Journal of Virology · doi:10.1128/jvi.01410-12 · Cited by 140 · see citing works
Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross
Gralinski, L. E., Ferris, M. T., Aylor, D. L., Whitmore, A. C., Green, R. R., Frieman, M. B., Deming, D., Menachery, V. D., Miller, D. R., Buus, R. J., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005504 · Cited by 140 · see citing works
Self-citationVijay, R., Hua, X., Meyerholz, D. K., Miki, Y., Yamamoto, K., Gelb, M. H., Murakami, M., & Perlman, S. M. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150632 · Cited by 139 · see citing works
Frieman, M. B., Yount, B. L., Agnihothram, S., Page, C., Donaldson, E., Roberts, A., Vogel, L., Woodruff, B., Scorpio, D. G., Subbarao, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05957-11 · Cited by 141 · see citing works
Self-citationColeman, C. M., Matthews, K. L., Goicochea, L., & Frieman, M. B. (2013) · Journal of General Virology · doi:10.1099/vir.0.060640-0 · Cited by 126 · see citing works
Self-citationCoronavirus non-structural protein 16: Evasion, attenuation, and possible treatments
Menachery, V. D., Debbink, K. M., & Baric, R. S. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.009 · Cited by 124 · see citing works
Self-citationEpigenetic Landscape during Coronavirus Infection
Schäfer, A., & Baric, R. S. (2017) · Pathogens · doi:10.3390/pathogens6010008 · Cited by 118 · see citing works
Self-citationVenkataraman, T., Coleman, C. M., & Frieman, M. B. (2017) · Journal of Virology · doi:10.1128/jvi.00182-17 · Cited by 113 · see citing works
Self-citationPage, C., Goicochea, L., Matthews, K. L., Zhang, Y., Klover, P. J., Holtzman, M. J., Hennighausen, L. G., & Frieman, M. B. (2012) · Journal of Virology · doi:10.1128/jvi.01689-12 · Cited by 102 · see citing works
Self-citationApproaches and Challenges in SARS-CoV-2 Vaccine Development
Dagotto, G., Yu, J., & Barouch, D. H. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.08.002 · Cited by 103 · see citing works
Zhang, Y.-Y., Li, B.-R., & Ning, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02033 · Cited by 103 · see citing works
Wang, S., Li, W., Wang, Z., Yang, W., Li, E., Xia, X., Yan, F., & Chiu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01917-x · Cited by 117 · see citing works
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
Sutton, T. C., & Subbarao, K. (2015) · Virology · doi:10.1016/j.virol.2015.02.030 · Cited by 96 · see citing works
Self-citationImmunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
Venditto, V. J., Haydar, D., Abdel‐Latif, A., Gensel, J. C., Anstead, M., Pitts, M. G., Creameans, J. W., Kopper, T. J., Peng, C., & Feola, D. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.574425 · Cited by 86 · see citing works
A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
Singh, A. K., Singh, R. S., Sarma, P., Batra, G., Joshi, R., Kaur, H., Sharma, A. R., Prakash, A., & Medhi, B. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00252-z · Cited by 82 · see citing works
Animal models for SARS‐CoV‐2 research: A comprehensive literature review
Pandey, K., Acharya, A., Mohan, M., Ng, C. L., Reid, S. P., & Byrareddy, S. N. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13907 · Cited by 78 · see citing works
Advances and gaps in SARS-CoV-2 infection models
Muñoz‐Fontela, C., Widerspick, L., Albrecht, R. A., Beer, M., Carroll, M. W., de Wit, E., Diamond, M., Dowling, W. E., Funnell, S. G. P., García‐Sastre, A., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010161 · Cited by 75 · see citing works
Potential role of interferons in treating COVID-19 patients
Abdolvahab, M. H., Moradi‐Kalbolandi, S., Zarei, M., Bose, D., Majidzadeh‐A, K., & Farahmand, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107171 · Cited by 70 · see citing works
A scoping review of the pathophysiology of COVID-19
Marik, P. E., Iglesias, J. I., Varón, J., & Kory, P. D. (2021) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211048026 · Cited by 70 · see citing works
A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
Neerukonda, S. N., & Katneni, U. (2020) · Pathogens · doi:10.3390/pathogens9060426 · Cited by 68 · see citing works
Boroujeni, M. E., Sekrecka, A., Antonczyk, A., Hassani, S., Sekrecki, M., Nowicka, H., Łopacinska, N., Olya, A., Kluzek, K., Wesoły, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888897 · Cited by 71 · see citing works
Sheahan, T. P., Whitmore, A. C., Long, K. M., Ferris, M. T., Rockx, B., Funkhouser, W. K., Donaldson, E., Gralinski, L. E., Collier, M., Heise, M. T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01805-10 · Cited by 69 · see citing works
Self-citationCameron, M. J., Kelvin, A. A., Leon, A. J., Cameron, C., Ran, L., Xu, L., Chu, Y.-K., Danesh, A., Yuan, F., Li, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045842 · Cited by 68 · see citing works
The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus
McDermott, J., Mitchell, H. D., Gralinski, L. E., Eisfeld, A. J., Josset, L., Bankhead, A., Neumann, G., Tilton, S. C., Schäfer, A., Li, C., et al. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0336-6 · Cited by 68 · see citing works
Self-citationProtection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein
Escriou, N., Callendret, B., Lorin, V., Combredet, C., Marianneau, P., Février, M., & Tangy, F. (2014) · Virology · doi:10.1016/j.virol.2014.01.002 · Cited by 67 · see citing works
LoPresti, M., Beck, D. B., Duggal, P., Cummings, D. A. T., & Solomon, B. D. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.08.007 · Cited by 65 · see citing works
Critical role of Syk-dependent STAT1 activation in innate antiviral immunity
Liu, S., Liao, Y., Chen, B., Chen, Y., Yu, Z., Wei, H., Zhang, L., Huang, S., Rothman, P. B., Gao, G. F., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108627 · Cited by 66 · see citing works
Self-citationInteraction of the innate immune system with positive-strand RNA virus replication organelles
Scutigliani, E. M., & Kikkert, M. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.05.007 · Cited by 63 · see citing works
Exportin 1 inhibition as antiviral therapy
Uddin, M. H., Zonder, J. A., & Azmi, A. S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.06.014 · Cited by 61 · see citing works
A molecular arms race between host innate antiviral response and emerging human coronaviruses
Wong, L.-Y. R., Lui, P., & Jin, D. (2016) · Virologica Sinica · doi:10.1007/s12250-015-3683-3 · Cited by 59 · see citing works
Mahlakõiv, T., Ritz, D., Mordstein, M., DeDiego, M. L., Enjuanes, L., Müller, M. A., Drosten, C., & Staeheli, P. (2012) · Journal of General Virology · doi:10.1099/vir.0.046284-0 · Cited by 58 · see citing works
Advances in the possible treatment of COVID-19: A review.
Chibber, P., Haq, S. A., Ahmed, I., Andrabi, N. I., & Singh, G. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173372 · Cited by 56 · see citing works
Recent Progress in Studies of Arterivirus- and Coronavirus-Host Interactions
Zhong, Y., Tan, Y. W., & Liu, D. X. (2012) · Viruses · doi:10.3390/v4060980 · Cited by 55 · see citing works
Hilligan, K. L., Namasivayam, S., Clancy, C. S., Baker, P. J., Old, S. I., Peluf, V., Amaral, E. P., Oland, S. D., O’Mard, D., Laux, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43447-0 · Cited by 55 · see citing works
Middle East respiratory syndrome and severe acute respiratory syndrome
Vijay, R., & Perlman, S. M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.01.011 · Cited by 54 · see citing works
Boudewijns, R., Thibaut, H. J., Kaptein, S. J. F., Li, R., Vergote, V., Seldeslachts, L., Keyzer, C. D., Bervoets, L., Sharma, S., Weyenbergh, J. V., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.23.056838 · Cited by 53 · see citing works
Can, A., & Coskun, H. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0164 · Cited by 49 · see citing works
COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
Aliabadi, H. A. M., Eivazzadeh‐Keihan, R., Parikhani, A. B., Mehraban, S. F., Maleki, A. R., Fereshteh, S., Bazaz, M., Zolriasatein, A., Bozorgnia, B., Rahmati, S., et al. (2022) · MedComm · doi:10.1002/mco2.115 · Cited by 49 · see citing works
Soltani‐Zangbar, M. S., Parhizkar, F., Ghaedi, E., Tarbiat, A., Motavalli, R., Alizadegan, A., Maleki, L. A., Rostamzadeh, D., Yousefzadeh, Y., Jadideslam, G., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00903-6 · Cited by 48 · see citing works
Zornetzer, G. A., Frieman, M. B., Rosenzweig, E., Korth, M. J., Page, C., Baric, R. S., & Katze, M. G. (2010) · Journal of Virology · doi:10.1128/jvi.01130-10 · Cited by 48 · see citing works
Self-citationQuan, C., Li, C., Ma, H., Li, Y., & Zhang, H. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-20 · Cited by 48 · see citing works
Ahmed-Hassan, H., Sisson, B., Shukla, R. K., Wijewantha, Y., Funderburg, N. T., Li, Z., Hayes, D., Demberg, T., & Liyanage, N. P. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01979 · Cited by 47 · see citing works
Potential health risks of mRNA-based vaccine therapy: A hypothesis
Acevedo‐Whitehouse, K. A., & Bruno, R. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111015 · Cited by 54 · see citing works
ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
Rawle, D. J., Le, T. T., Dumenil, T. D., Yan, K., Tang, B., Nguyen, W., Watterson, D., Modhiran, N., Hobson‐Peters, J., Bishop, C., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009723 · Cited by 40 · see citing works
Shi, W., Hou, X., Li, X., Peng, H., Shi, M., Jiang, Q., Liu, X., Ji, Y. S., Yao, Y., He, C., et al. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.11.009 · Cited by 41 · see citing works
Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2
Sanclemente-Alamán, I., Moreno-Jiménez, L., Benito-Martín, M. S., Canales-Aguirre, A., Matias-Guiu, J., Matías-Guíu, J., & Gómez-Pinedo, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02163 · Cited by 35 · see citing works
Alefishat, E. A., Jelinek, H. F., Mousa, M., Tay, G. K., & AlSafar, H. S. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.01.007 · Cited by 36 · see citing works
Saksena, N. K., Bonam, S. R., & Saksena, M. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.581726 · Cited by 36 · see citing works
Malbon, A. J., Meli, M. L., Barker, E., Davidson, A. D., Tasker, S., & Kipar, A. (2018) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2018.11.001 · Cited by 35 · see citing works
Immune response against epidemic coronaviruses
Pashenkov, M. V., & Khaitov, R. M. (2020) · Immunologiya · doi:10.33029/0206-4952-2020-41-1-5-18 · Cited by 37 · see citing works
COVID-19: The Immune Responses and Clinical Therapy Candidates
Zhand, S., Jazi, M. S., Mohammadi, S., Rasekhi, R. T., Rostamian, G., Kalani, M. R., Rostamian, A., George, J., & Douglas, M. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155559 · Cited by 33 · see citing works
Coronavirus in human diseases: Mechanisms and advances in clinical treatment
Lin, P., Wang, M., Wei, Y., Kim, T., & Wei, X. (2020) · MedComm · doi:10.1002/mco2.26 · Cited by 31 · see citing works
Cell‐mediated immunity to SARS‐CoV‐2
Wang, X., & Gui, J. (2020) · Pediatric Investigation · doi:10.1002/ped4.12228 · Cited by 31 · see citing works
Grunwell, J. R., Stephenson, S. T., Mohammad, A. F., Jones, K. D., Mason, C., Opolka, C., & Fitzpatrick, A. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-76122-1 · Cited by 30 · see citing works
Selection of animal models for COVID-19 research
Kumar, S., Yadav, P., Srinivasan, R., & Perumal, N. (2020) · VirusDisease · doi:10.1007/s13337-020-00637-4 · Cited by 35 · see citing works
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
Ahmad, T., Chaudhuri, R., Joshi, M. C., Almatroudi, A., Rahmani, A. H., & Ali, S. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.588409 · Cited by 28 · see citing works
- Authors
- Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., & Baric, R. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- National Institutes of Health (US)
- Corresponding author
- Baric, Ralph S.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-08
- Volume
- 6
- Issue
- 4
- Pages
- e1000849
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2851658
- OpenAlex
- W2049537492
- Cited by
- 158
- References
- 55
- Citations by year
- 2026: 1 · 2024: 10 · 2023: 8 · 2022: 14 · 2021: 14 · 2020: 51 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 11 · 2015: 6 · 2014: 5 · 2013: 5 · 2012: 13
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- UNC Libraries
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI075297, AI059443, R01AI075297, AI66542, F32AI066542, P01AI059443)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- SARS-CoV, STAT1, interferon signaling, type I interferon, interferon-gamma, interferon lambda, viral pathogenesis, innate immunity, STAT1 knockout mice, lung lesions, disseminated viral infection, cell proliferation regulation
- MeSH terms
- Animals, Female, Flow Cytometry, Interferon Type I, Interferon-gamma, Gene Expression, Cytokines, In Situ Hybridization, Receptors, Interferon, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, STAT1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review